Here, we showed that Bay11-7082, the NF-κB inhibitor, could alleviate the partial EMT and renal fibrosis induced by Snai1 upregulation, as well as resolve the inflammatory response in the interstitium. This evidence concerns the gene SNAI1 and renal fibrosis.